STAT

Opinion: Assisted living and Covid-19: the next Kirkland might not be a nursing home

With the national spotlight turned on nursing homes following the #Covid19 outbreak at a Washington state facility, the nearly 1 million residents of assisted living communities are getting lost in…

With the national spotlight turned on nursing homes following the Covid-19 outbreak at the Life Care Center in Kirkland, Wash., that led to the deaths of 35 residents, the nearly 1 million residents of assisted living communities are getting lost in the shadows. They need the same kind of attention as nursing home residents.

The Centers for Medicare and Medicaid Services and the Centers for Disease Control and Prevention aim to beef up infection prevention and control in nursing homes. Unless similar efforts are made in assisted living communities, we will almost certainly see Kirkland-type outbreaks in them.

Assisted living, also of long-term care services. Assisted living communities provide a combination of housing, personal care services, and health care designed for individuals who need assistance with normal daily activities but who want to be as independent as possible. There are nearly 29,000 assisted living communities across the U.S. caring for more than 800,000 residents. Most residents are age 85 or older, and many have one or more chronic illnesses — the very people who are at high risk for developing serious complications of Covid-19.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks